Featured Research

from universities, journals, and other organizations

Aortic valve replacement that doesn’t require open heart surgery

Date:
November 5, 2013
Source:
Loyola University Health System
Summary:
Researchers are reporting positive results from a landmark clinical trial of an investigational aortic valve that is deployed with a catheter, without open heart surgery.

Loyola University Medical Center is the only Chicago hospital participating in a landmark clinical trial of an artificial aortic heart valve that does not require open heart surgery.

Related Articles


First results from the trial were announced at the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco. Results were positive, with high survival rates and low rates of stroke.

"This is a major breakthrough," said Fred Leya, MD, co-principal investigator at the Loyola site. "Not only did patients live longer, but their quality of life improved substantially." The other co-investigator at Loyola is Mamdouh Bakhos, MD.

Jeffrey J. Popma, MD, director of Interventional Cardiology at the Beth Israel Deaconess Medical Center, Boston, and co-principal investigator of the clinical trial, presented the results at TCT.

The heart valve is called the Medtronic CoreValve® System. It is deployed with a catheter, which is inserted into an artery in the groin and guided up to the heart. Once in place, the artificial valve takes over the function of a diseased valve.

The valve is being studied in patients with severe aortic stenosis. This condition occurs when the heart's aortic valve is narrowed, restricting blood flow from the heart to the body. The valve doesn't open properly, forcing the heart to work harder to pump blood. Symptoms include fatigue, dizziness, chest pain/pressure, heart murmur, shortness of breath during activity, heart palpitations and fainting. Aortic stenosis can lead to heart failure and death. About 100,000 people in the United States have aortic stenosis. Currently in the United States, the standard treatment is to replace the aortic valve through open-heart surgery.

The initial phase of the trial included 471 patients at 40 centers who were extremely frail and had complex medical problems that made them too sick for open heart surgery.

One year after implantation, 76 percent of the patients were still alive, a remarkable result considering how ill they were. And only 4.1 percent had experienced major strokes by one year, which was significantly lower than expected.

The valves worked well, with strong blood flow and low leakage rates.

There was a huge improvement in patients' quality of life, as measured on a 100-point scale. At one year, scores improved 27.4 points on the KCCQ scale. (By comparison, 5 points is considered important and 20 points is considered a very large improvement.)

Investigators are expected to report on the trial's other study of patients who are not as frail as those in the initial group. Half of these new patients have been randomly assigned to receive CoreValve and half have been assigned to conventional open heart surgery.

More than 45,000 patients in more than 60 countries have received the CoreValve System. In the United States, use of the device is limited to clinical trials.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "Aortic valve replacement that doesn’t require open heart surgery." ScienceDaily. ScienceDaily, 5 November 2013. <www.sciencedaily.com/releases/2013/11/131105093120.htm>.
Loyola University Health System. (2013, November 5). Aortic valve replacement that doesn’t require open heart surgery. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/11/131105093120.htm
Loyola University Health System. "Aortic valve replacement that doesn’t require open heart surgery." ScienceDaily. www.sciencedaily.com/releases/2013/11/131105093120.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins